8-K//Current report
Apellis Pharmaceuticals, Inc. 8-K
Accession 0001193125-25-153429
$APLSCIK 0001492422operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 7:09 AM ET
Size
134.8 KB
Accession
0001193125-25-153429
Documents
- 8-Kd940210d8k.htmPrimary
8-K
- EX-101.SCHapls-20250701.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABapls-20250701_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREapls-20250701_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-153429-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd940210d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492422
Filing Metadata
- Form type
- 8-K
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 7:09 AM ET
- Size
- 134.8 KB